Epstein Secrets

SA World Economic Forum Annual Meeting EFTA R1_02010994 EFTA02686120 David T. Ellwood Thomas Enders Ditlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Escobar Shelly Esque Dan Esty John Evans Stuart Evans Bob Every Dean Chief Executive Officer

Chairman of the Board President Chief Executive and Chairman, Committee of Experts Chairman Arnold Saltzman Professor of Professional Practice US Finance and Business Editor Business Editor Deputy Permanent Representative and Chargé d'Affaires a.i. Chairman and Managing Director Executive Director

d Systems A/S Denmark Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charle

ean Commission. Brussels Jean-Marie Guéhenno Arnold Saltzman Professor of Columbia University USA Professional Practice Francesco P. Guerrera US Finance and Business Editor The Financial Times USA Robert Guest Business Editor The Economist United Kingdom Momar Guèye Deputy Permanent Representa

d Systems A/S Denmark Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charle

ean Commission. Brussels Jean-Marie Guéhenno Arnold Saltzman Professor of Columbia University USA Professional Practice Francesco P. Guerrera US Finance and Business Editor The Financial Times USA Robert Guest Business Editor The Economist United Kingdom Momar Guèye Deputy Permanent Representa